On Premise Limfinity License and FreezerPro On Premise Support License Renewals
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The National Institutes of Health (NIH), Office of the Director, intends to procure On-Premise Limfinity License and FreezerPro On-Premise Support License Renewals on a sole source basis from Azenta US, Inc. This combined synopsis/solicitation is for essential software licenses and support for the NIH Undiagnosed Diseases Program (UDP). Responses from interested parties are due by April 20, 2026, at 9:00 AM EDT.
Scope of Work
This acquisition covers the renewal of two critical software licenses and associated support services:
On-Premise Limfinity License/Platform for UDP/UDPics:
- Annual license and support renewal for the Azenta Limfinity platform, specifically the UDPics system, which is a patient data system for the NIH UDP.
- Includes email support, framework technical support, access to new framework releases, and configuration troubleshooting.
- Requires Premium Support Service, including a designated liaison for UDP to perform refinement and rectify problems.
- Provides backend API access, server maintenance, version updates, and concurrent user licenses.
- Period of Performance: June 1, 2026, through May 31, 2027.
FreezerPro On-Premise Support/Renewal Support License:
- Support, maintenance, and updates for the Azenta FreezerPro Sample Management system, vital for managing patient and research laboratory samples within the UDP.
- Includes support, bioinformatic expertise, scripting refinement, Limfinity integration, maintenance, version updates, and concurrent user licenses.
- Period of Performance: July 27, 2026, through July 26, 2027.
Both systems are crucial for the UDP's collaborative work between laboratory and clinical personnel, enabling efficient management of patient data and biorepository samples.
Contract & Timeline
- Type: Combined Synopsis/Solicitation (RFQ)
- NAICS: 513210 (Business Size Standard: $34M)
- Set-Aside: Not set aside for small business.
- Sole Source: Intended award to Azenta US, Inc. under 41 U.S.C. 253(c)(1), FAR 6.302.
- Place of Performance: Bethesda, MD 20892.
- Response Due: April 20, 2026, 9:00 AM EDT.
- Published: April 15, 2026.
Evaluation
This is a notice of intent to award on a sole source basis. Interested vendors who believe they can meet the requirements must submit a quotation demonstrating their bona-fide capabilities. Submissions should include descriptive literature, warranties, delivery timeframe, and other information proving the ability to provide all specified services and products.
Additional Notes
- Quotations must reference Solicitation number 75N98026Q00175.
- Offerors must include their Unique Entity ID (UEI), Taxpayer Identification Number (TIN), and certification of business size.
- A valid and active SAM registration is required for award and throughout the contract lifecycle. Failure to maintain SAM registration can jeopardize award or result in non-payment.
- All questions must be sent via email to robinsti@mail.nih.gov with the solicitation number in the subject line.